TECAN GROUP AG N (TEN.F)
- Previous Close
180.30 - Open
180.30 - Bid 178.80 x --
- Ask 179.50 x --
- Day's Range
180.30 - 180.30 - 52 Week Range
168.60 - 225.80 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
2.3B - Beta (5Y Monthly) 0.97
- PE Ratio (TTM)
32.04 - EPS (TTM)
5.64 - Earnings Date Aug 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 22, 2024
- 1y Target Est
--
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized OEM system; Cavro, a standard and customized OEM component; and onsite and depot repairs, as well as remote services and digital solutions. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.
www.tecan.com3,074
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: TEN.F
View MorePerformance Overview: TEN.F
Trailing total returns as of 5/29/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TEN.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TEN.F
View MoreValuation Measures
Market Cap
2.28B
Enterprise Value
2.18B
Trailing P/E
31.97
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.31
Price/Book (mrq)
1.50
Enterprise Value/Revenue
2.19
Enterprise Value/EBITDA
13.82
Financial Highlights
Profitability and Income Statement
Profit Margin
7.24%
Return on Assets (ttm)
2.08%
Return on Equity (ttm)
4.86%
Revenue (ttm)
934.28M
Net Income Avi to Common (ttm)
67.66M
Diluted EPS (ttm)
5.64
Balance Sheet and Cash Flow
Total Cash (mrq)
406.01M
Total Debt/Equity (mrq)
22.39%
Levered Free Cash Flow (ttm)
101.22M